Is Castle Biosciences, Inc. (CSTL) a Buy, Sell, or Hold?
NASDAQ : CSTL
Castle Biosciences, Inc. — Analyst Ratings
$24.51 USD
$0.61 (2.57%)
- Volume
- 296K
- Average Volume
- 397.1K
- Market Capitalization
- $743.39M
- P/E Ratio
- -57.07
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $44.28
- Year Low
- $14.59
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.75
Analyst Consensus Summary
Consensus Rating
Sell
11 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-38.7%
vs Current Price
Price Target
$40.00
Average TargetPrice Target Range
Lowest Target
$35.00
-30.0% DOWNSIDE
Average Target
$40.00
Median Estimate
Highest Target
$47.00
-47.9% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 11
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 11 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Canaccord Genuity | Kyle Mikson | $40 | $25.04 | 2026-04-20 09:00 AM | 59.7% |
| KeyBanc | Paul Knight | $50 | $39.16 | 2026-01-29 03:40 PM | 27.7% |
| Guggenheim | Subbu Nambi | $47 | $43.08 | 2026-01-26 09:35 AM | 9.1% |
| BTIG | Mark Massaro | $50 | $37.97 | 2025-12-12 07:23 AM | 31.7% |
| Guggenheim | Subbu Nambi | $30 | $20.1 | 2025-03-28 07:10 AM | 49.3% |